Ask OpenScientist

Ask a research question about Dracunculiasis. OpenScientist will conduct autonomous deep research using the Disorder Mechanisms Knowledge Base and PubMed literature (typically 10-30 minutes).

Submitting...

Do not include personal health information in your question. Questions and results are cached in your browser's local storage.

3
Pathophys.
7
Phenotypes
2
Treatments
6
References
1
Deep Research

Pathophysiology

3
Larval transmission by copepods
Cyclops copepods transmit guinea worm larvae to humans.
Show evidence (1 reference)
PMID:27162746 SUPPORT
"The transmitting vectors are Cyclops copepods (water fleas), which are tiny free-swimming crustaceans usually found abundantly in freshwater ponds."
The abstract identifies Cyclops copepods as transmitting vectors.
Worm emergence and skin ulceration
Approximately one year after ingestion of infected water, the mature female worm migrates to the skin surface and emerges slowly and painfully, typically through a lower extremity. A blister forms prior to emergence, which ruptures to form a painful ulcer through which the worm protrudes.
Show evidence (2 references)
PMID:14970098 SUPPORT
"One year after human ingestion of infected water a female adult worm emerges, typically from a lower extremity, producing painful ulcers that can impair mobility for up to several weeks."
Describes the characteristic emergence of the worm through skin ulcers on lower extremities.
PMID:11932231 SUPPORT
"is caused by the large female of the nematode Dracunculus medinensis, which emerges painfully and slowly from the skin, usually on the lower limbs"
Confirms painful emergence of the worm through skin on lower limbs.
Disability and socioeconomic impact
Guinea worm emergence causes temporary disability lasting weeks, typically coinciding with peak agricultural activities, leading to significant economic hardship in affected communities.
Show evidence (3 references)
PMID:14970098 SUPPORT
"This disease occurs annually when agricultural activities are at their peak. Large proportions of economically productive individuals of a village are usually affected simultaneously, resulting in decreased agricultural productivity and economic hardship."
Describes the socioeconomic impact of disability during agricultural peak.
PMID:11932231 SUPPORT
"It has a significant socioeconomic impact because of the temporary disability that it causes."
Confirms significant socioeconomic impact from temporary disability.
PMID:1825339 SUPPORT Human Clinical
"The impact of dracunculiasis on agricultural, economic and recreational activities was considerable, with the infected farmers being unable to attend to their farms at the critical farming period."
Field study in Nigeria documenting disability and economic impact on farming communities.

Phenotypes

7
Integument 2
Skin Ulceration at Worm Emergence Site VERY_FREQUENT Skin ulcer (HP:0200042)
Show evidence (2 references)
PMID:14970098 SUPPORT Human Clinical
"One year after human ingestion of infected water a female adult worm emerges, typically from a lower extremity, producing painful ulcers that can impair mobility for up to several weeks."
Describes painful ulcer formation as a hallmark of worm emergence.
PMID:1825339 SUPPORT Human Clinical
"ulcers were predominantly in the ankles and feet, particularly among young children"
Field survey documents lower-extremity ulcer localization.
Cutaneous Blister Formation VERY_FREQUENT Abnormal blistering of the skin (HP:0008066)
Show evidence (1 reference)
PMID:1825339 SUPPORT Human Clinical
"dracunculiasis patients were usually unaware of their infection 3-5 days before the appearance of a bleb"
Documents bleb (blister) formation as the initial clinical sign before worm emergence.
Nervous System 1
Impaired Mobility and Disability VERY_FREQUENT Gait disturbance (HP:0001288)
Show evidence (2 references)
PMID:14970098 SUPPORT Human Clinical
"producing painful ulcers that can impair mobility for up to several weeks"
Documents impaired mobility lasting several weeks as a key clinical consequence.
PMID:1825339 SUPPORT Human Clinical
"Severe disability was related to age, site and number of ulcers, and the form of selected treatment."
Nigerian field study identifies factors determining severity of disability.
Constitutional 3
Pain at Emergence Site VERY_FREQUENT Pain (HP:0012531)
Show evidence (2 references)
PMID:34735420 SUPPORT Human Clinical
"The worm typically emerges through the skin on a lower limb of the host 1 year after infection, causing pain and disability"
MMWR report confirms pain as a cardinal feature of worm emergence.
PMID:33119555 SUPPORT Human Clinical
"The worm typically emerges through the skin on a lower limb approximately 1 year after infection, resulting in pain and disability"
Confirms pain and disability as primary clinical consequences.
Myalgia FREQUENT Myalgia (HP:0003326)
Show evidence (1 reference)
PMID:2935634 SUPPORT Human Clinical
"Localized myalgia (55%), chronic monoarthralgia (35%) and chronic synovitis of the knee (10%) were the main presentations."
Prospective study of 20 patients with calcified guinea worm showing myalgia as the most common rheumatic manifestation (55%).
Arthralgia OCCASIONAL Arthralgia (HP:0002829)
Show evidence (1 reference)
PMID:2935634 SUPPORT Human Clinical
"Localized myalgia (55%), chronic monoarthralgia (35%) and chronic synovitis of the knee (10%) were the main presentations."
Chronic monoarthralgia found in 35% of patients with calcified guinea worm.
Other 1
Secondary Tetanus Infection FREQUENT
Show evidence (1 reference)
PMID:1825339 SUPPORT Human Clinical
"Mortality from secondary tetanus infection was associated with outbreak of dracunculiasis."
Documents secondary tetanus infection as a serious and potentially fatal complication of dracunculiasis ulcers.
💊

Treatments

2
No Specific Treatment Available
There is no vaccine or medicine to prevent or treat dracunculiasis. Management relies on slow mechanical extraction of the worm by winding it around a stick, wound care, and prevention of secondary infections. Eradication depends entirely on preventive measures.
Show evidence (2 references)
PMID:14970098 SUPPORT Human Clinical
"Eradication of guinea worm disease depends on prevention, as there is no effective treatment or vaccine."
Confirms absence of pharmacological treatment or vaccine.
PMID:23798694 SUPPORT Human Clinical
"No vaccine or medicine is available against the disease: eradication is being achieved by implementing preventive measures."
WHO review confirms no available vaccine or medicine, eradication through prevention only.
Water Filtration and Safe Water Provision
Primary preventive intervention involves filtering drinking water to remove copepods, providing safe water sources, and applying temephos larvicide to unsafe water.
Show evidence (2 references)
PMID:14970098 SUPPORT Human Clinical
"These programs have educated local populations on how to filter drinking water to remove the parasite and how to prevent those with ulcers from infecting drinking-water sources."
Describes community-based water filtration as a key preventive intervention.
PMID:23798694 SUPPORT Human Clinical
"filtering drinking water and accessing water from improved sources and preventing infected individuals from wading or swimming in drinking-water sources"
WHO report confirms water filtration and improved water sources as core preventive measures.
{ }

Source YAML

click to show
name: Dracunculiasis
creation_date: '2026-01-26T15:56:41Z'
updated_date: '2026-05-02T00:00:00Z'
category: Infectious Disease
description: >-
  Dracunculiasis (guinea worm disease) is caused by Dracunculus medinensis and is
  transmitted through contaminated drinking water containing infected copepods.
  Approximately one year after ingestion, the female worm emerges painfully through
  the skin, typically on a lower extremity, producing blisters, ulcers, pain, and
  temporary disability. There is no vaccine or medicine available; eradication relies
  entirely on preventive measures. The disease is targeted for global eradication.
disease_term:
  term:
    id: MONDO:0016472
    label: dracunculiasis
  preferred_term: Dracunculiasis
parents:
- Helminth infection
- Neglected tropical disease
infectious_agent:
- name: Dracunculus medinensis
  infectious_agent_term:
    preferred_term: Dracunculus medinensis
    term:
      id: NCBITaxon:318479
      label: Dracunculus medinensis
  description: Guinea worm nematode causing dracunculiasis.
  evidence:
  - reference: PMID:27162746
    reference_title: "Dracunculiasis in oral and maxillofacial surgery."
    supports: SUPPORT
    snippet: "Dracunculiasis, otherwise known as guinea worm disease (GWD), is caused by infection with the nematode Dracunculus medinensis."
    explanation: The abstract identifies D. medinensis as the causative nematode.
transmission:
- name: Contaminated drinking water with infected copepods
  description: Humans acquire infection by drinking water containing infected Cyclops copepods.
  evidence:
  - reference: PMID:27162746
    reference_title: "Dracunculiasis in oral and maxillofacial surgery."
    supports: SUPPORT
    snippet: "Humans can acquire GWD by drinking water that contains vectors infected with guinea worm larvae."
    explanation: The abstract describes waterborne transmission via infected copepods.
  - reference: PMID:14970098
    reference_title: "Dracunculiasis (guinea worm disease)."
    supports: SUPPORT
    snippet: "Guinea worm disease is transmitted by drinking water containing copepods (water fleas) that are infected with Dracunculiasis medinensis larvae."
    explanation: Confirms waterborne transmission via copepods infected with D. medinensis larvae.
- name: Consumption of infected aquatic animals
  description: >-
    In recent years, transmission also appears to occur through eating fish or
    other aquatic animals harboring D. medinensis larvae.
  evidence:
  - reference: PMID:34735420
    reference_title: "Progress Toward Global Eradication of Dracunculiasis, January 2020-June 2021."
    supports: SUPPORT
    snippet: "is traditionally acquired by drinking water containing copepods (water fleas) infected with D. medinensis larvae, but in recent years also appears increasingly to be transmitted by eating fish or other aquatic animals"
    explanation: MMWR report documents emerging fish/aquatic animal transmission route.
pathophysiology:
- name: Larval transmission by copepods
  description: Cyclops copepods transmit guinea worm larvae to humans.
  evidence:
  - reference: PMID:27162746
    reference_title: "Dracunculiasis in oral and maxillofacial surgery."
    supports: SUPPORT
    snippet: "The transmitting vectors are Cyclops copepods (water fleas), which are tiny free-swimming crustaceans usually found abundantly in freshwater ponds."
    explanation: The abstract identifies Cyclops copepods as transmitting vectors.
- name: Worm emergence and skin ulceration
  description: >-
    Approximately one year after ingestion of infected water, the mature female worm
    migrates to the skin surface and emerges slowly and painfully, typically through
    a lower extremity. A blister forms prior to emergence, which ruptures to form a
    painful ulcer through which the worm protrudes.
  evidence:
  - reference: PMID:14970098
    reference_title: "Dracunculiasis (guinea worm disease)."
    supports: SUPPORT
    snippet: "One year after human ingestion of infected water a female adult worm emerges, typically from a lower extremity, producing painful ulcers that can impair mobility for up to several weeks."
    explanation: Describes the characteristic emergence of the worm through skin ulcers on lower extremities.
  - reference: PMID:11932231
    reference_title: "Dracunculiasis (Guinea worm disease) and the eradication initiative."
    supports: SUPPORT
    snippet: "is caused by the large female of the nematode Dracunculus medinensis, which emerges painfully and slowly from the skin, usually on the lower limbs"
    explanation: Confirms painful emergence of the worm through skin on lower limbs.
- name: Disability and socioeconomic impact
  description: >-
    Guinea worm emergence causes temporary disability lasting weeks, typically
    coinciding with peak agricultural activities, leading to significant economic
    hardship in affected communities.
  evidence:
  - reference: PMID:14970098
    reference_title: "Dracunculiasis (guinea worm disease)."
    supports: SUPPORT
    snippet: "This disease occurs annually when agricultural activities are at their peak. Large proportions of economically productive individuals of a village are usually affected simultaneously, resulting in decreased agricultural productivity and economic hardship."
    explanation: Describes the socioeconomic impact of disability during agricultural peak.
  - reference: PMID:11932231
    reference_title: "Dracunculiasis (Guinea worm disease) and the eradication initiative."
    supports: SUPPORT
    snippet: "It has a significant socioeconomic impact because of the temporary disability that it causes."
    explanation: Confirms significant socioeconomic impact from temporary disability.
  - reference: PMID:1825339
    reference_title: "Clinical manifestations, disability and use of folk medicine in dracunculus infection in Nigeria."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The impact of dracunculiasis on agricultural, economic and recreational activities was considerable, with the infected farmers being unable to attend to their farms at the critical farming period."
    explanation: Field study in Nigeria documenting disability and economic impact on farming communities.
phenotypes:
- category: Dermatological
  name: Skin Ulceration at Worm Emergence Site
  frequency: VERY_FREQUENT
  description: >-
    Painful ulcers form at the site of worm emergence, typically on the lower
    extremities (ankles and feet). These ulcers result from the blister that forms
    prior to the worm protruding through the skin.
  phenotype_term:
    preferred_term: Skin ulcer
    term:
      id: HP:0200042
      label: Skin ulcer
  evidence:
  - reference: PMID:14970098
    reference_title: "Dracunculiasis (guinea worm disease)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "One year after human ingestion of infected water a female adult worm emerges, typically from a lower extremity, producing painful ulcers that can impair mobility for up to several weeks."
    explanation: Describes painful ulcer formation as a hallmark of worm emergence.
  - reference: PMID:1825339
    reference_title: "Clinical manifestations, disability and use of folk medicine in dracunculus infection in Nigeria."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "ulcers were predominantly in the ankles and feet, particularly among young children"
    explanation: Field survey documents lower-extremity ulcer localization.
- category: Dermatological
  name: Cutaneous Blister Formation
  frequency: VERY_FREQUENT
  description: >-
    A bleb or blister appears on the skin 3-5 days before the worm emerges.
    The blister subsequently ruptures, allowing the worm to protrude.
  phenotype_term:
    preferred_term: Cutaneous blistering
    term:
      id: HP:0008066
      label: Abnormal blistering of the skin
  evidence:
  - reference: PMID:1825339
    reference_title: "Clinical manifestations, disability and use of folk medicine in dracunculus infection in Nigeria."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "dracunculiasis patients were usually unaware of their infection 3-5 days before the appearance of a bleb"
    explanation: Documents bleb (blister) formation as the initial clinical sign before worm emergence.
- category: Musculoskeletal
  name: Pain at Emergence Site
  frequency: VERY_FREQUENT
  description: >-
    Intense pain accompanies worm emergence through the skin, causing significant
    disability and impaired mobility lasting up to several weeks.
  phenotype_term:
    preferred_term: Pain
    term:
      id: HP:0012531
      label: Pain
  evidence:
  - reference: PMID:34735420
    reference_title: "Progress Toward Global Eradication of Dracunculiasis, January 2020-June 2021."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The worm typically emerges through the skin on a lower limb of the host 1 year after infection, causing pain and disability"
    explanation: MMWR report confirms pain as a cardinal feature of worm emergence.
  - reference: PMID:33119555
    reference_title: "Progress Toward Global Eradication of Dracunculiasis, January 2019-June 2020."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "The worm typically emerges through the skin on a lower limb approximately 1 year after infection, resulting in pain and disability"
    explanation: Confirms pain and disability as primary clinical consequences.
- category: Musculoskeletal
  name: Impaired Mobility and Disability
  frequency: VERY_FREQUENT
  description: >-
    Severe disability related to the site and number of ulcers impairs mobility
    for weeks. Disability is the most significant clinical consequence and is
    worsened by secondary infections.
  phenotype_term:
    preferred_term: Gait disturbance
    term:
      id: HP:0001288
      label: Gait disturbance
  evidence:
  - reference: PMID:14970098
    reference_title: "Dracunculiasis (guinea worm disease)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "producing painful ulcers that can impair mobility for up to several weeks"
    explanation: Documents impaired mobility lasting several weeks as a key clinical consequence.
  - reference: PMID:1825339
    reference_title: "Clinical manifestations, disability and use of folk medicine in dracunculus infection in Nigeria."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Severe disability was related to age, site and number of ulcers, and the form of selected treatment."
    explanation: Nigerian field study identifies factors determining severity of disability.
- category: Musculoskeletal
  name: Myalgia
  frequency: FREQUENT
  description: >-
    Localized muscle pain is a common rheumatic manifestation, particularly
    associated with calcified guinea worm remnants in previously infected individuals.
  phenotype_term:
    preferred_term: Myalgia
    term:
      id: HP:0003326
      label: Myalgia
  evidence:
  - reference: PMID:2935634
    reference_title: "Parasitic rheumatism: rheumatic manifestations associated with calcified guinea worm."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Localized myalgia (55%), chronic monoarthralgia (35%) and chronic synovitis of the knee (10%) were the main presentations."
    explanation: Prospective study of 20 patients with calcified guinea worm showing myalgia as the most common rheumatic manifestation (55%).
- category: Musculoskeletal
  name: Arthralgia
  frequency: OCCASIONAL
  description: >-
    Chronic joint pain, particularly monoarthralgia, can occur in association
    with calcified guinea worm remnants.
  phenotype_term:
    preferred_term: Arthralgia
    term:
      id: HP:0002829
      label: Arthralgia
  evidence:
  - reference: PMID:2935634
    reference_title: "Parasitic rheumatism: rheumatic manifestations associated with calcified guinea worm."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Localized myalgia (55%), chronic monoarthralgia (35%) and chronic synovitis of the knee (10%) were the main presentations."
    explanation: Chronic monoarthralgia found in 35% of patients with calcified guinea worm.
- category: Infectious
  name: Secondary Tetanus Infection
  frequency: FREQUENT
  description: >-
    Tetanus is a serious secondary infection of emergence-site ulcers and has
    been associated with mortality in endemic areas.
  phenotype_term:
    preferred_term: Secondary tetanus infection
  evidence:
  - reference: PMID:1825339
    reference_title: "Clinical manifestations, disability and use of folk medicine in dracunculus infection in Nigeria."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Mortality from secondary tetanus infection was associated with outbreak of dracunculiasis."
    explanation: Documents secondary tetanus infection as a serious and potentially fatal complication of dracunculiasis ulcers.
treatments:
- name: No Specific Treatment Available
  description: >-
    There is no vaccine or medicine to prevent or treat dracunculiasis. Management
    relies on slow mechanical extraction of the worm by winding it around a stick,
    wound care, and prevention of secondary infections. Eradication depends entirely
    on preventive measures.
  evidence:
  - reference: PMID:14970098
    reference_title: "Dracunculiasis (guinea worm disease)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "Eradication of guinea worm disease depends on prevention, as there is no effective treatment or vaccine."
    explanation: Confirms absence of pharmacological treatment or vaccine.
  - reference: PMID:23798694
    reference_title: "Dracunculiasis (guinea worm disease): eradication without a drug or a vaccine."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "No vaccine or medicine is available against the disease: eradication is being achieved by implementing preventive measures."
    explanation: WHO review confirms no available vaccine or medicine, eradication through prevention only.
- name: Water Filtration and Safe Water Provision
  description: >-
    Primary preventive intervention involves filtering drinking water to remove
    copepods, providing safe water sources, and applying temephos larvicide to
    unsafe water.
  evidence:
  - reference: PMID:14970098
    reference_title: "Dracunculiasis (guinea worm disease)."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "These programs have educated local populations on how to filter drinking water to remove the parasite and how to prevent those with ulcers from infecting drinking-water sources."
    explanation: Describes community-based water filtration as a key preventive intervention.
  - reference: PMID:23798694
    reference_title: "Dracunculiasis (guinea worm disease): eradication without a drug or a vaccine."
    supports: SUPPORT
    evidence_source: HUMAN_CLINICAL
    snippet: "filtering drinking water and accessing water from improved sources and preventing infected individuals from wading or swimming in drinking-water sources"
    explanation: WHO report confirms water filtration and improved water sources as core preventive measures.
references:
- reference: DOI:10.1128/cmr.15.2.223-246.2002
  title: Dracunculiasis (Guinea Worm Disease) and the Eradication Initiative
  found_in:
  - Dracunculiasis-deep-research-falcon.md
  findings:
  - statement: Dracunculiasis, also known as guinea worm disease, is caused by the large female of the nematode Dracunculus medinensis, which emerges painfully and slowly from the skin, usually on the lower limbs.
    supporting_text: Dracunculiasis, also known as guinea worm disease, is caused by the large female of the nematode Dracunculus medinensis, which emerges painfully and slowly from the skin, usually on the lower limbs.
    evidence:
    - reference: DOI:10.1128/cmr.15.2.223-246.2002
      reference_title: Dracunculiasis (Guinea Worm Disease) and the Eradication Initiative
      supports: SUPPORT
      evidence_source: OTHER
      snippet: Dracunculiasis, also known as guinea worm disease, is caused by the large female of the nematode Dracunculus medinensis, which emerges painfully and slowly from the skin, usually on the lower limbs.
      explanation: Deep research cited this publication as relevant literature for Dracunculiasis.
- reference: DOI:10.15585/mmwr.mm7344a1
  title: Progress Toward Global Dracunculiasis (Guinea Worm Disease) Eradication, January 2023–June 2024
  found_in:
  - Dracunculiasis-deep-research-falcon.md
  findings:
  - statement: Progress Toward Global Dracunculiasis (Guinea Worm Disease) Eradication, January 2023–June 2024
    supporting_text: Progress Toward Global Dracunculiasis (Guinea Worm Disease) Eradication, January 2023–June 2024
- reference: DOI:10.3390/tropicalmed7110366
  title: 'Guinea Worm Disease: A Neglected Diseases on the Verge of Eradication'
  found_in:
  - Dracunculiasis-deep-research-falcon.md
  findings:
  - statement: Dracunculiasis, also known as Guinea worm disease (GWD), is a neglected tropical disease (NTD) caused by a parasite (Dracunculus medinensis).
    supporting_text: Dracunculiasis, also known as Guinea worm disease (GWD), is a neglected tropical disease (NTD) caused by a parasite (Dracunculus medinensis).
    evidence:
    - reference: DOI:10.3390/tropicalmed7110366
      reference_title: 'Guinea Worm Disease: A Neglected Diseases on the Verge of Eradication'
      supports: SUPPORT
      evidence_source: OTHER
      snippet: Dracunculiasis, also known as Guinea worm disease (GWD), is a neglected tropical disease (NTD) caused by a parasite (Dracunculus medinensis).
      explanation: Deep research cited this publication as relevant literature for Dracunculiasis.
- reference: DOI:10.4269/ajtmh.23-0681
  title: Predicting the Environmental Suitability and Identifying Climate and Sociodemographic Correlates of Guinea Worm (Dracunculus medinensis) in Chad
  found_in:
  - Dracunculiasis-deep-research-falcon.md
  findings:
  - statement: A comprehensive understanding of the spatial distribution and correlates of infection are key for the planning of disease control programs and assessing the feasibility of elimination and/or eradication.
    supporting_text: A comprehensive understanding of the spatial distribution and correlates of infection are key for the planning of disease control programs and assessing the feasibility of elimination and/or eradication.
    evidence:
    - reference: DOI:10.4269/ajtmh.23-0681
      reference_title: Predicting the Environmental Suitability and Identifying Climate and Sociodemographic Correlates of Guinea Worm (Dracunculus medinensis) in Chad
      supports: SUPPORT
      evidence_source: OTHER
      snippet: A comprehensive understanding of the spatial distribution and correlates of infection are key for the planning of disease control programs and assessing the feasibility of elimination and/or eradication.
      explanation: Deep research cited this publication as relevant literature for Dracunculiasis.
- reference: DOI:10.4269/ajtmh.23-0889
  title: 'Slaying the Serpent: A Research Agenda to Expand Intervention Development and Accelerate Guinea Worm Eradication Efforts'
  found_in:
  - Dracunculiasis-deep-research-falcon.md
  findings:
  - statement: Dracunculiasis, also known as Guinea worm disease, is targeted to become the second human disease and first parasitic infection to be eradicated.
    supporting_text: Dracunculiasis, also known as Guinea worm disease, is targeted to become the second human disease and first parasitic infection to be eradicated.
    evidence:
    - reference: DOI:10.4269/ajtmh.23-0889
      reference_title: 'Slaying the Serpent: A Research Agenda to Expand Intervention Development and Accelerate Guinea Worm Eradication Efforts'
      supports: SUPPORT
      evidence_source: HUMAN_CLINICAL
      snippet: Dracunculiasis, also known as Guinea worm disease, is targeted to become the second human disease and first parasitic infection to be eradicated.
      explanation: Deep research cited this publication as relevant literature for Dracunculiasis.
- reference: DOI:10.53854/liim-3104-9
  title: 'The current state of knowledge on dracunculiasis: a narrative review of a rare neglected disease'
  found_in:
  - Dracunculiasis-deep-research-falcon.md
  findings:
  - statement: 'The current state of knowledge on dracunculiasis: a narrative review of a rare neglected disease'
    supporting_text: 'The current state of knowledge on dracunculiasis: a narrative review of a rare neglected disease'
📚

References & Deep Research

References

6
Dracunculiasis (Guinea Worm Disease) and the Eradication Initiative
1 finding
Dracunculiasis, also known as guinea worm disease, is caused by the large female of the nematode Dracunculus medinensis, which emerges painfully and slowly from the skin, usually on the lower limbs.
"Dracunculiasis, also known as guinea worm disease, is caused by the large female of the nematode Dracunculus medinensis, which emerges painfully and slowly from the skin, usually on the lower limbs."
Show evidence (1 reference)
"Dracunculiasis, also known as guinea worm disease, is caused by the large female of the nematode Dracunculus medinensis, which emerges painfully and slowly from the skin, usually on the lower limbs."
Deep research cited this publication as relevant literature for Dracunculiasis.
Progress Toward Global Dracunculiasis (Guinea Worm Disease) Eradication, January 2023–June 2024
1 finding
Progress Toward Global Dracunculiasis (Guinea Worm Disease) Eradication, January 2023–June 2024
"Progress Toward Global Dracunculiasis (Guinea Worm Disease) Eradication, January 2023–June 2024"
Guinea Worm Disease: A Neglected Diseases on the Verge of Eradication
1 finding
Dracunculiasis, also known as Guinea worm disease (GWD), is a neglected tropical disease (NTD) caused by a parasite (Dracunculus medinensis).
"Dracunculiasis, also known as Guinea worm disease (GWD), is a neglected tropical disease (NTD) caused by a parasite (Dracunculus medinensis)."
Show evidence (1 reference)
"Dracunculiasis, also known as Guinea worm disease (GWD), is a neglected tropical disease (NTD) caused by a parasite (Dracunculus medinensis)."
Deep research cited this publication as relevant literature for Dracunculiasis.
Predicting the Environmental Suitability and Identifying Climate and Sociodemographic Correlates of Guinea Worm (Dracunculus medinensis) in Chad
1 finding
A comprehensive understanding of the spatial distribution and correlates of infection are key for the planning of disease control programs and assessing the feasibility of elimination and/or eradication.
"A comprehensive understanding of the spatial distribution and correlates of infection are key for the planning of disease control programs and assessing the feasibility of elimination and/or eradication."
Show evidence (1 reference)
"A comprehensive understanding of the spatial distribution and correlates of infection are key for the planning of disease control programs and assessing the feasibility of elimination and/or eradication."
Deep research cited this publication as relevant literature for Dracunculiasis.
Slaying the Serpent: A Research Agenda to Expand Intervention Development and Accelerate Guinea Worm Eradication Efforts
1 finding
Dracunculiasis, also known as Guinea worm disease, is targeted to become the second human disease and first parasitic infection to be eradicated.
"Dracunculiasis, also known as Guinea worm disease, is targeted to become the second human disease and first parasitic infection to be eradicated."
Show evidence (1 reference)
DOI:10.4269/ajtmh.23-0889 SUPPORT Human Clinical
"Dracunculiasis, also known as Guinea worm disease, is targeted to become the second human disease and first parasitic infection to be eradicated."
Deep research cited this publication as relevant literature for Dracunculiasis.
The current state of knowledge on dracunculiasis: a narrative review of a rare neglected disease
1 finding
The current state of knowledge on dracunculiasis: a narrative review of a rare neglected disease
"The current state of knowledge on dracunculiasis: a narrative review of a rare neglected disease"

Deep Research

1
Falcon
Dracunculiasis (Guinea Worm Disease): Disease Characteristics Research Report
Edison Scientific Literature 29 citations 2026-04-04T13:57:19.375511

Dracunculiasis (Guinea Worm Disease): Disease Characteristics Research Report

Target disease: Dracunculiasis
Category: Infectious disease (helminthic nematode infection)
Primary agent: Dracunculus medinensis (nematode) (hopkins2024progresstowardglobal pages 1-2, cairncross2002dracunculiasis(guineaworm pages 1-3)

Executive summary (current understanding and key 2023–2024 updates)

Dracunculiasis is a water- and food-associated parasitic infection in which a gravid female D. medinensis migrates to the skin and emerges—typically ~10–14 months after infection—causing painful blistering/ulceration and frequent secondary bacterial complications. (hopkins2024progresstowardglobal pages 1-2, simonetti2023thecurrentstate pages 1-2, pellegrino2022guineawormdisease pages 2-5). The eradication program reduced global incidence from an estimated 3.5 million cases/year (1986) to 13 cases (2022), but elimination is increasingly constrained by animal infections (especially dogs) and probable food-borne/paratenic transmission, motivating a One Health “endgame” research agenda (2024) and new requirements for demonstrating absence of animal infections during certification. (hopkins2024progresstowardglobal pages 2-3, delea2024slayingtheserpent pages 1-2, hopkins2024progresstowardglobal pages 6-7).

As of June 2024, dracunculiasis remained endemic in five countries (Angola, Chad, Ethiopia, Mali, South Sudan). In 2023, there were 14 human cases and 886 animal infections worldwide; during January–June 2024, 3 human cases and 297 animal infections were reported. (hopkins2024progresstowardglobal pages 1-2, hopkins2024progresstowardglobal pages 2-3).

A key 2024 research development is the use of ensemble machine-learning ecological niche/suitability modeling in Chad using 2010–2022 surveillance data and remotely sensed covariates to proactively target surveillance and intervention resources; the most important correlates included proximity to permanent surface water, precipitation, farmland/cropland, and land-surface temperature, with clustering along the Chari River. (eneanya2024predictingtheenvironmental pages 1-1, eneanya2024predictingtheenvironmental pages 4-6, eneanya2024predictingtheenvironmental pages 1-3).

Compact evidence map

Aspect Current best-supported details Notes on source type Key citations
Definition / agent Dracunculiasis (Guinea worm disease) is a neglected tropical helminthiasis caused by the nematode Dracunculus medinensis; adult gravid females migrate through subcutaneous tissues and emerge through skin, usually in the lower limbs. MMWR + peer-reviewed reviews (hopkins2024progresstowardglobal pages 1-2, simonetti2023thecurrentstate pages 1-2, cairncross2002dracunculiasis(guineaworm pages 1-3)
Incubation / timing Incubation is typically about 10-14 months (~1 year) from infection to worm emergence; patients are often asymptomatic until emergence. MMWR + peer-reviewed reviews (hopkins2024progresstowardglobal pages 1-2, hopkins2024progresstowardglobal pages 2-3, pellegrino2022guineawormdisease pages 2-5, cairncross2002dracunculiasis(guineaworm pages 1-3)
Transmission routes Classical route: drinking water containing infected copepods. Current understanding also supports food-borne transmission via inadequately cooked aquatic animals and/or paratenic/transport hosts such as frogs and fish, especially relevant in Chad. MMWR + peer-reviewed reviews (hopkins2024progresstowardglobal pages 1-2, simonetti2023thecurrentstate pages 2-4, simonetti2023thecurrentstate pages 1-2, hopkins2024progresstowardglobal pages 6-7)
Endemic countries as of June 2024 As of June 2024, dracunculiasis remained endemic in 5 countries: Angola, Chad, Ethiopia, Mali, and South Sudan. WHO certification now also requires absence of indigenous animal infections. MMWR + research agenda paper (hopkins2024progresstowardglobal pages 1-2, hopkins2024progresstowardglobal pages 2-3, delea2024slayingtheserpent pages 1-2, hopkins2024progresstowardglobal pages 6-7)
Human cases: 2022, 2023, Jan-Jun 2024 Global human cases fell to 13 in 2022, increased slightly to 14 in 2023, and 3 cases were reported during Jan-Jun 2024 (same as Jan-Jun 2023). Long-run decline is from ~3.5 million estimated annual cases in 1986. MMWR primary program surveillance (hopkins2024progresstowardglobal pages 2-3, hopkins2024progresstowardglobal pages 6-7, hopkins2023progresstowarderadication pages 1-2, hopkins2023progresstowarderadication pages 2-3)
Animal infections: 2022, 2023, Jan-Jun 2024 Animal infections were 686 in 2022, 886 in 2023, and 297 during Jan-Jun 2024. In 2023, Chad reported 407 infected dogs and Cameroon 248 infected dogs; Chad had 496 total animal infections in 2023 (407 dogs, 89 cats). MMWR primary program surveillance (hopkins2024progresstowardglobal pages 1-2, hopkins2024progresstowardglobal pages 2-3, hopkins2024progresstowardglobal pages 6-7, hopkins2023progresstowarderadication pages 1-2)
Key animal hosts Dogs are now the dominant animal host affecting eradication; cats and baboons are also involved, and a wild-caught genet was reported in South Sudan in 2023. Infections in animals have surpassed human cases since 2012. MMWR + peer-reviewed review + research agenda (hopkins2024progresstowardglobal pages 2-3, delea2024slayingtheserpent pages 1-2, hopkins2024progresstowardglobal pages 6-7, hopkins2023progresstowarderadication pages 1-2)
Major interventions Core interventions are case containment, prevention of water contamination, cloth/pipe filtration of drinking water, treatment of unsafe water with temephos (Abate), provision of safe water, health education, safe cooking of aquatic animals, safe disposal of fish entrails, active village surveillance, cash rewards, and tethering of infected dogs. MMWR + peer-reviewed reviews (hopkins2024progresstowardglobal pages 1-2, hopkins2024progresstowardglobal pages 5-6, hopkins2023progresstowarderadication pages 6-7, hopkins2023progresstowarderadication pages 1-2, agua2025comparativeanalysisof pages 67-71)
Key challenges Main endgame obstacles are animal reservoirs (especially dogs), possible food-borne/paratenic transmission, insecurity/civil unrest limiting access (notably Mali and parts of South Sudan/CAR border areas), under-detection, and lack of vaccines, therapeutics, or validated prepatent diagnostics. MMWR + end-stage challenge/research agenda papers (delea2024slayingtheserpent pages 1-2, hopkins2024progresstowardglobal pages 6-7, hopkins2023progresstowarderadication pages 6-7, tutu2023stoppingandtracing pages 1-3)
Recent development: One Health agenda (2024) A 2024 research agenda proposed a systems-informed One Health approach to accelerate eradication, prioritizing tools for animal reservoir investigation, environmental surveillance, diagnostics, and intervention development aligned with a 2030 certification target. Peer-reviewed 2024 research agenda (delea2024slayingtheserpent pages 1-2)
Recent development: environmental suitability modeling (2024) Ensemble machine-learning mapping in Chad (2010-2022 surveillance data) identified clustering along the Chari River and linked suitability to proximity to permanent rivers/inland lakes, farmlands, land-surface temperature, and precipitation to help target surveillance and interventions. Peer-reviewed 2024 modeling study (cairncross2002dracunculiasis(guineaworm pages 1-1)
Recent development: diagnostics / qPCR Recent reviews note that conventional PCR is slow, while a Guinea worm qPCR has high sensitivity/specificity for confirming adult female infections in humans and animals; however, no widely implemented test yet detects prepatent infection for routine field control. Peer-reviewed review + research agenda (simonetti2023thecurrentstate pages 2-4, delea2024slayingtheserpent pages 1-2)

Table: This table summarizes the most current, best-supported facts about dracunculiasis, emphasizing 2022-2024 epidemiology, animal reservoirs, interventions, and recent research. It is useful as a compact evidence map for a disease knowledge base or briefing document.

1. Disease information

1.1 What is the disease?

Dracunculiasis (Guinea worm disease) is a neglected tropical parasitic disease caused by the nematode Dracunculus medinensis. Humans (and now multiple animal hosts) are infected primarily through exposure associated with contaminated freshwater sources; clinical disease manifests when the adult gravid female migrates subcutaneously and emerges through the skin, producing a painful blister/ulcer and disability. (hopkins2024progresstowardglobal pages 1-2, simonetti2023thecurrentstate pages 1-2, cairncross2002dracunculiasis(guineaworm pages 1-3).

1.2 Key identifiers and synonyms

  • Synonyms/alternative names: Guinea worm disease; dracunculosis (cairncross2002dracunculiasis(guineaworm pages 1-1, cairncross2002dracunculiasis(guineaworm pages 1-3).
  • Key identifiers: the accessible source corpus did not contain ontology or coding crosswalks (MONDO, MeSH, ICD-10/11, Orphanet, OMIM). Therefore, these identifiers cannot be tool-cited here and should be filled from authoritative coding resources (e.g., WHO ICD and NLM MeSH browsers).

1.3 Evidence provenance (patient-level vs aggregated)

Most current “disease status” information is aggregated program surveillance (national Guinea Worm Eradication Programs; compiled in CDC MMWR). (hopkins2024progresstowardglobal pages 1-2, hopkins2024progresstowardglobal pages 2-3). Clinical descriptions and pathophysiology are from peer-reviewed narrative and systematic reviews. (simonetti2023thecurrentstate pages 1-2, pellegrino2022guineawormdisease pages 2-5).

2. Etiology

2.1 Primary cause

The etiologic agent is the parasitic nematode Dracunculus medinensis. (hopkins2024progresstowardglobal pages 1-2, cairncross2002dracunculiasis(guineaworm pages 1-3).

2.2 Risk factors (environmental/exposure)

Core exposure risk: ingesting contaminated drinking water containing infected copepods (Cyclops and related genera) carrying infective larvae. (cairncross2002dracunculiasis(guineaworm pages 1-3).

Emerging/expanded exposure hypotheses (major recent theme): food-borne infection through ingestion of aquatic animals functioning as transport or paratenic hosts (fish/frogs) and/or inadequately cooked aquatic animals, which is emphasized as relevant to Chad’s epidemiology and to increasing dog infections. (simonetti2023thecurrentstate pages 2-4, simonetti2023thecurrentstate pages 1-2, hopkins2024progresstowardglobal pages 6-7).

Environmental correlates (Chad, 2010–2022 surveillance; 2024 modeling): proximity to permanent surface waters (rivers/inland lakes), precipitation patterns (including rainy season effects and temporary ponds), farmland/cropland, and land-surface temperature were major correlates of predicted suitability. (eneanya2024predictingtheenvironmental pages 1-1, eneanya2024predictingtheenvironmental pages 4-6, eneanya2024predictingtheenvironmental pages 1-3).

2.3 Protective factors

Protective factors are primarily behavioral and environmental interventions: filtering drinking water, provision of copepod-free/safe water sources, larviciding unsafe water sources with temephos, health education to prevent contaminated water exposure, adequate cooking of aquatic animals, and safe disposal of fish entrails (reducing dog exposure). (hopkins2024progresstowardglobal pages 1-2, hopkins2023progresstowarderadication pages 1-2).

2.4 Gene–environment interactions

No human genetic susceptibility or protective variants are established in the accessible evidence base for this disease; risk is dominated by exposure ecology and behavior. (hopkins2024progresstowardglobal pages 1-2, simonetti2023thecurrentstate pages 1-2).

3. Phenotypes

3.1 Clinical presentation (signs/symptoms)

Typical clinical course is characterized by a long asymptomatic incubation followed by localized inflammatory skin lesions that permit worm emergence. - Latency: patients are often asymptomatic for ~1 year after infection. (pellegrino2022guineawormdisease pages 2-5).
- Lesion evolution: painful papule enlarges to blister; blister ruptures to ulcer; gravid female emerges and releases larvae if lesion contacts water. (simonetti2023thecurrentstate pages 1-2, cairncross2002dracunculiasis(guineaworm pages 1-3).
- Anatomic distribution: typically distal extremities, commonly lower limbs (below knees). (pellegrino2022guineawormdisease pages 2-5, cairncross2002dracunculiasis(guineaworm pages 1-3).

Complications: frequent secondary bacterial infection (reported as common and >50% of lesions in a recent review), cellulitis, abscesses, sepsis, pyogenic arthritis/septic arthritis, and tetanus are described as important complications. (simonetti2023thecurrentstate pages 2-4, pellegrino2022guineawormdisease pages 2-5).

3.2 Suggested HPO terms (examples; to be verified in HPO)

Because ontology identifiers were not retrieved directly from HPO in this run, below are suggested phenotype concepts for mapping: - Painful blister/skin ulceration at extremities (blistering; skin ulcer; limb pain) (simonetti2023thecurrentstate pages 1-2, pellegrino2022guineawormdisease pages 2-5)
- Cellulitis / abscess (simonetti2023thecurrentstate pages 2-4, pellegrino2022guineawormdisease pages 2-5)
- Septic arthritis / arthritis (simonetti2023thecurrentstate pages 2-4, pellegrino2022guineawormdisease pages 2-5)
- Fever / rash / nausea (systemic symptoms around emergence) (pellegrino2022guineawormdisease pages 2-5)
- Sepsis (simonetti2023thecurrentstate pages 2-4)

3.3 Onset and progression

  • Onset: delayed onset, usually ~10–14 months after infection. (hopkins2024progresstowardglobal pages 1-2, hopkins2024progresstowardglobal pages 2-3).
  • Course: emergence is painful and disabling; individuals may immerse limbs in water for relief, which facilitates transmission by larval release. (pellegrino2022guineawormdisease pages 2-5, cairncross2002dracunculiasis(guineaworm pages 1-3).

4. Genetic / molecular information

4.1 Human genetics

Dracunculiasis is not a Mendelian genetic disorder; no causal human gene is required for diagnosis. No human pathogenic variants were identified in the accessible sources. (hopkins2024progresstowardglobal pages 1-2, simonetti2023thecurrentstate pages 1-2).

4.2 Pathogen genetics and molecular tools

  • Species confirmation across hosts: genetic studies used by eradication programs confirm that worms emerging from animals are D. medinensis, supporting that animal infections are part of the same eradication problem. (hopkins2023progresstowarderadication pages 1-2).
  • Molecular diagnostics: a narrative review reports that serology has limited diagnostic value; conventional PCR turnaround can be slow, whereas a Guinea worm qPCR is described as having high sensitivity/specificity for confirming adult female infections in humans and animals. (simonetti2023thecurrentstate pages 2-4).
  • Immunologic correlates reported in active infection: elevated parasite-specific IgG1/IgG4 with relatively low IgE and depressed IFN-γ have been described, though these are not currently positioned as routine biomarkers for field control. (simonetti2023thecurrentstate pages 2-4).

5. Environmental information

5.1 Environmental and lifestyle factors

Transmission is tightly linked to freshwater ecology, where copepods can host infective larvae and where human water procurement and aquatic food practices create exposure routes. (cairncross2002dracunculiasis(guineaworm pages 1-3, hopkins2024progresstowardglobal pages 6-7). Farming/fishing contexts and proximity to major rivers (e.g., Chari River basin in Chad) are highlighted as important correlates of suitability. (eneanya2024predictingtheenvironmental pages 1-1, eneanya2024predictingtheenvironmental pages 1-3).

5.2 Infectious agent taxonomy

The causative agent is Dracunculus medinensis (nematode; family Dracunculidae). (simonetti2023thecurrentstate pages 1-2, cairncross2002dracunculiasis(guineaworm pages 1-3).

6. Mechanism / pathophysiology

6.1 Causal chain (trigger → mechanism → manifestation)

  1. Exposure: ingestion of infected copepods in drinking water (classical) and/or ingestion of infected aquatic animals (suspected/important in Chad). (cairncross2002dracunculiasis(guineaworm pages 1-3, hopkins2024progresstowardglobal pages 6-7).
  2. Larval migration/maturation: larvae penetrate the intestinal wall and migrate through connective tissues; adults mature and mate over months. (simonetti2023thecurrentstate pages 1-2, cairncross2002dracunculiasis(guineaworm pages 1-3).
  3. Delayed clinical disease: after ~10–14 months, the gravid female migrates subcutaneously to distal sites, provoking a painful blister/ulcer. (hopkins2024progresstowardglobal pages 1-2, cairncross2002dracunculiasis(guineaworm pages 1-3).
  4. Transmission event: contact with water induces larval release, perpetuating the cycle via copepods. (cairncross2002dracunculiasis(guineaworm pages 1-3).

6.2 Biological processes and cell types (ontology suggestions)

Direct GO/CL IDs were not retrieved in the accessible corpus; suggested mappings include: - GO (process concepts): inflammatory response; wound healing; leukocyte-mediated immunity; response to parasite. (simonetti2023thecurrentstate pages 2-4, simonetti2023thecurrentstate pages 1-2).
- CL (cell concepts): neutrophils/monocytes/macrophages involved in blister fluid inflammatory infiltrates (conceptual; review-level). (simonetti2023thecurrentstate pages 1-2).

6.3 Recent mechanistic research directions (2024)

A 2024 eradication “research agenda” emphasizes that eradication progressed largely without vaccines/therapeutics/early diagnostics, and it prioritizes development of new interventions, diagnostics (including prepatent detection), and environmental surveillance tools within a One Health framework. (delea2024slayingtheserpent pages 1-2).

7. Anatomical structures affected

7.1 Organ/tissue level

Primary pathology is in skin and subcutaneous connective tissue of distal extremities (often lower limbs), with secondary involvement of soft tissues and joints due to bacterial complications (cellulitis, abscess, septic arthritis). (simonetti2023thecurrentstate pages 2-4, pellegrino2022guineawormdisease pages 2-5, cairncross2002dracunculiasis(guineaworm pages 1-3).

7.2 Suggested UBERON mapping (concepts)

Not directly retrievable from Uberon in this run; suggested sites include lower limb (leg/foot), skin, subcutaneous tissue, and synovial joints (for septic arthritis). (pellegrino2022guineawormdisease pages 2-5, cairncross2002dracunculiasis(guineaworm pages 1-3).

8. Temporal development

  • Incubation period: ~10–14 months (hopkins2024progresstowardglobal pages 1-2, hopkins2024progresstowardglobal pages 2-3).
  • Seasonality (programmatic relevance): rainy season and related water-body dynamics influence suitability and predicted risk in Chad; peaks are associated with rainfall/temporary pond formation and river-associated fishing practices. (eneanya2024predictingtheenvironmental pages 8-9, eneanya2024predictingtheenvironmental pages 1-1).

9. Inheritance and population

9.1 Epidemiology (recent statistics)

  • Endemic countries (June 2024): Angola, Chad, Ethiopia, Mali, South Sudan. (hopkins2024progresstowardglobal pages 1-2).
  • Global human cases: 13 (2022) → 14 (2023) → 3 (Jan–Jun 2024). (hopkins2024progresstowardglobal pages 2-3, hopkins2023progresstowarderadication pages 2-3).
  • Global animal infections: 686 (2022) → 886 (2023) → 297 (Jan–Jun 2024). (hopkins2024progresstowardglobal pages 2-3, hopkins2023progresstowarderadication pages 1-2).
  • Animal infections dominate: animal infections have surpassed human cases since 2012, constituting the principal “endgame” challenge. (hopkins2023progresstowarderadication pages 1-2, hopkins2024progresstowardglobal pages 6-7).

9.2 Geographic distribution and hotspots

Chad accounts for a large share of remaining infections, and transmission is described as linked to aquatic animal consumption. (hopkins2024progresstowardglobal pages 2-3, hopkins2024progresstowardglobal pages 6-7). In Chad, suitability modeling shows clustering in southern regions along the Chari River and predicted suitability near borders with Cameroon and the Central African Republic. (eneanya2024predictingtheenvironmental pages 1-1, eneanya2024predictingtheenvironmental pages 1-3).

9.3 Demographics

The accessible sources do not provide robust sex ratio or age distribution estimates; where case examples are given (e.g., a 47-year-old woman in CAR), these are anecdotal and not population distributions. (sudan2024datefebruary26 pages 3-5).

10. Diagnostics

10.1 Clinical/laboratory diagnosis

  • Case definition used in eradication surveillance: a person with skin lesion(s) from which one or more worms emerge, with laboratory confirmation at CDC as D. medinensis. (hopkins2024progresstowardglobal pages 2-3).
  • Specimen confirmation: specimens requiring confirmation are sent to CDC, and national programs rely on village-based reporting and supervisory verification. (hopkins2024progresstowardglobal pages 1-2, hopkins2023progresstowarderadication pages 1-2).
  • Serology: described as of limited value in a 2023 narrative review. (simonetti2023thecurrentstate pages 2-4).
  • PCR/qPCR: conventional PCR described as slow; qPCR described as sensitive/specific for confirming adult female infections. (simonetti2023thecurrentstate pages 2-4).

10.2 Surveillance and certification diagnostics (public health implementation)

  • Active village-based surveillance: includes daily household searches by trained volunteers and monthly reporting systems; “rumor” reporting and investigations are used operationally. (hopkins2024progresstowardglobal pages 1-2, hopkins2023progresstowarderadication pages 2-3).
  • WHO certification standard: at least 3 consecutive years of adequate nationwide surveillance with no indigenous human case or animal infection is required. (hopkins2024progresstowardglobal pages 2-3, hopkins2023progresstowarderadication pages 1-2).

10.3 Differential diagnosis

Differentials are not enumerated in the accessible text excerpts; clinically, any blistering ulcerative lesion with secondary infection could mimic other causes, but definitive diagnosis is often direct observation of an emerging worm. (hopkins2024progresstowardglobal pages 2-3, pellegrino2022guineawormdisease pages 2-5).

11. Outcome / prognosis

The disease is typically not described as high-mortality in the accessible corpus, but it produces substantial morbidity through pain, disability, and complications such as cellulitis, sepsis, destructive joint disease, and tetanus. (simonetti2023thecurrentstate pages 2-4, pellegrino2022guineawormdisease pages 2-5). Quantitative survival or long-term disability statistics were not present in the retrieved excerpts.

12. Treatment

12.1 Pharmacotherapy / vaccines

No vaccine or drug treatment exists for dracunculiasis in current eradication program descriptions. (hopkins2024progresstowardglobal pages 1-2).

12.2 Supportive and interventional care

Clinical management is primarily supportive: careful extraction/management of emerging worms, wound care, and treatment/prevention of secondary bacterial infection and tetanus complications (not quantified in the accessible excerpts). (pellegrino2022guineawormdisease pages 2-5, simonetti2023thecurrentstate pages 2-4).

12.3 Candidate MAXO terms (conceptual)

MAXO identifiers were not retrieved directly; suggested actions include wound care, antiparasitic removal/extraction procedure, antibiotic therapy for secondary infection, tetanus prophylaxis, safe water provision, water filtration, larvicide application, health education, and animal tethering. (hopkins2024progresstowardglobal pages 1-2, hopkins2023progresstowarderadication pages 1-2).

13. Prevention

Prevention is the cornerstone of eradication and includes multiple complementary community-based interventions: - Water safety: filtration of drinking water; provision of safe (copepod-free) drinking water sources. (hopkins2024progresstowardglobal pages 1-2, hopkins2023progresstowarderadication pages 1-2).
- Vector control: treatment of unsafe water sources with temephos (Abate). (hopkins2023progresstowarderadication pages 1-2, agua2025comparativeanalysisof pages 67-71).
- Transmission interruption/case containment: prevent infected humans and animals from entering water sources; structured containment criteria are used operationally. (hopkins2024progresstowardglobal pages 1-2).
- Food-related interventions: adequate cooking of aquatic animals and safe disposal of fish entrails to reduce transmission to dogs. (hopkins2024progresstowardglobal pages 1-2).
- Behavior change and incentives: health education and cash rewards for reporting; rewards have been increased in some settings to enhance detection. (hopkins2024progresstowardglobal pages 5-6, hopkins2024progresstowardglobal pages 6-7).

14. Other species / natural disease (One Health)

14.1 Non-human hosts and eradication impact

Since 2012, infections have been detected in domesticated dogs (first detected in Chad), and later in cats and baboons; animal infections now constitute the dominant remaining burden and complicate eradication. (delea2024slayingtheserpent pages 1-2, hopkins2023progresstowarderadication pages 1-2). A wild-caught genet infection was reported for the first time in South Sudan in 2023 (hopkins2024progresstowardglobal pages 6-7). A WHO/CDC wrap-up notes additional animal surveillance events, including an infected donkey detected in Mali (Dec 2023) and inspection of dead/trapped baboons in Ethiopia. (sudan2024datefebruary26 pages 3-5).

14.2 Zoonotic framing

The current eradication challenge resembles a One Health problem (human–animal–environment transmission). The 2024 research agenda explicitly adopts a systems-informed One Health approach to tool development and evidence generation for certification. (delea2024slayingtheserpent pages 1-2).

15. Model organisms / experimental systems

The accessible corpus did not include laboratory animal model descriptions for D. medinensis infection in a way that supports structured annotation. Current work emphasized is field surveillance, ecological modeling, and development of diagnostics and interventions rather than experimental model systems. (delea2024slayingtheserpent pages 1-2, eneanya2024predictingtheenvironmental pages 1-1).

Recent developments and expert analysis (prioritizing 2023–2024)

2023: Updated clinical synthesis and diagnostic discussion

A 2023 narrative review emphasizes an evolving transmission paradigm: in addition to classical waterborne copepod infection, ingestion of frogs (paratenic) or fish (transport) hosts may contribute to current epidemiology and increasing animal infections, and it notes qPCR improvements for confirmatory testing alongside limited serologic utility. (simonetti2023thecurrentstate pages 2-4, simonetti2023thecurrentstate pages 1-2).

2024: CDC MMWR eradication update (programmatic “ground truth”)

The 2024 MMWR provides primary surveillance statistics (2022–mid-2024), highlights animal infections as the main constraint to near-term eradication, and documents real-world intervention implementation (temephos, filtration, tethering, cooking guidance, rewards, village surveillance, and WHO certification criteria). (hopkins2024progresstowardglobal pages 1-2, hopkins2024progresstowardglobal pages 2-3, hopkins2024progresstowardglobal pages 6-7).

2024: Research agenda for endgame tool development

The 2024 “Slaying the Serpent” agenda argues that eradication is being pursued despite the absence of vaccines/therapeutics/prepatent diagnostics and proposes prioritized work streams (diagnostics, surveillance, intervention development) coordinated to a 2030 certification target, explicitly motivated by the emergence of animal infections since 2012. (delea2024slayingtheserpent pages 1-2).

2024: Environmental suitability mapping as an operational tool

Eneanya et al. (published online July 9, 2024) used 2010–2022 village-level infection records (dominated by dog records) and ensemble modeling to generate 1 km² suitability surfaces and identify major covariates (surface water proximity, precipitation, farmland, LST), intended to optimize surveillance and intervention allocation as Chad approaches elimination. (eneanya2024predictingtheenvironmental pages 1-3, eneanya2024predictingtheenvironmental pages 4-6, eneanya2024predictingtheenvironmental pages 9-10).

Limitations of this tool-based report (important for knowledge-base curation)

  1. ICD/MeSH/MONDO/Orphanet/OMIM identifiers were not present in the retrieved full-text evidence and therefore cannot be provided with tool-citations here; these should be sourced directly from ICD and MeSH browsers and MONDO/Orphanet portals during curation.
  2. PMIDs were not available in the retrieved text snippets/metadata for the key 2023–2024 papers in this run; URLs/DOIs and publication months/years are provided instead.
  3. Several template elements (e.g., QoL instruments, prevalence/incidence per 100,000, robust demographic distributions, detailed differential diagnosis lists, experimental model organism phenotyping) were not available in the accessible excerpts and are flagged as gaps.

Key sources (with URLs and publication dates)

  • Hopkins DR et al. “Progress Toward Global Dracunculiasis (Guinea Worm Disease) Eradication, January 2023–June 2024.” MMWR, Nov 2024. https://doi.org/10.15585/mmwr.mm7344a1 (hopkins2024progresstowardglobal pages 1-2, hopkins2024progresstowardglobal pages 2-3).
  • Delea MG et al. “Slaying the Serpent: A Research Agenda to Expand Intervention Development and Accelerate Guinea Worm Eradication Efforts.” Am J Trop Med Hyg, Sep 2024. https://doi.org/10.4269/ajtmh.23-0889 (delea2024slayingtheserpent pages 1-2).
  • Eneanya OA et al. “Predicting the Environmental Suitability and Identifying Climate and Sociodemographic Correlates of Guinea Worm (Dracunculus medinensis) in Chad.” Am J Trop Med Hyg, online Jul 9, 2024; issue Sep 2024. https://doi.org/10.4269/ajtmh.23-0681 (eneanya2024predictingtheenvironmental pages 1-1, eneanya2024predictingtheenvironmental pages 4-6, eneanya2024predictingtheenvironmental pages 9-10).
  • Simonetti O et al. “The current state of knowledge on dracunculiasis: a narrative review of a rare neglected disease.” Le infezioni in medicina, Dec 2023. https://doi.org/10.53854/liim-3104-9 (simonetti2023thecurrentstate pages 1-2, simonetti2023thecurrentstate pages 2-4).
  • Cairncross S et al. “Dracunculiasis (Guinea Worm Disease) and the Eradication Initiative.” Clinical Microbiology Reviews, Apr 2002. https://doi.org/10.1128/cmr.15.2.223-246.2002 (cairncross2002dracunculiasis(guineaworm pages 1-3).

References

  1. (hopkins2024progresstowardglobal pages 1-2): Donald R. Hopkins, Adam J. Weiss, Sarah Yerian, Yujing Zhao, Sarah G.H. Sapp, and Vitaliano A. Cama. Progress toward global dracunculiasis (guinea worm disease) eradication, january 2023–june 2024. Morbidity and Mortality Weekly Report, 73:991-998, Nov 2024. URL: https://doi.org/10.15585/mmwr.mm7344a1, doi:10.15585/mmwr.mm7344a1. This article has 14 citations.

  2. (cairncross2002dracunculiasis(guineaworm pages 1-3): Sandy Cairncross, Ralph Muller, and Nevio Zagaria. Dracunculiasis (guinea worm disease) and the eradication initiative. Clinical Microbiology Reviews, 15:223-246, Apr 2002. URL: https://doi.org/10.1128/cmr.15.2.223-246.2002, doi:10.1128/cmr.15.2.223-246.2002. This article has 237 citations and is from a highest quality peer-reviewed journal.

  3. (simonetti2023thecurrentstate pages 1-2): Omar Simonetti, V. Zerbato, C. Maurel, Lavinia Cosimi, Stella Babich, Fabio Cavalli, Stefano Di Bella, D. Pavia, C. Pesaresi, and Roberto Luzzati. The current state of knowledge on dracunculiasis: a narrative review of a rare neglected disease. Le infezioni in medicina, 31 4:500-508, Dec 2023. URL: https://doi.org/10.53854/liim-3104-9, doi:10.53854/liim-3104-9. This article has 6 citations.

  4. (pellegrino2022guineawormdisease pages 2-5): Carmen Pellegrino, Giulia Patti, Michele Camporeale, Alessandra Belati, Roberta Novara, Roberta Papagni, Luisa Frallonardo, Lucia Diella, Giacomo Guido, Elda De Vita, Valentina Totaro, Francesco Vladimiro Segala, Nicola Veronese, Sergio Cotugno, Davide Fiore Bavaro, Giovanni Putoto, Nazario Bevilacqua, Chiara Castellani, Emanuele Nicastri, Annalisa Saracino, and Francesco Di Gennaro. Guinea worm disease: a neglected diseases on the verge of eradication. Tropical Medicine and Infectious Disease, 7:366, Nov 2022. URL: https://doi.org/10.3390/tropicalmed7110366, doi:10.3390/tropicalmed7110366. This article has 19 citations.

  5. (hopkins2024progresstowardglobal pages 2-3): Donald R. Hopkins, Adam J. Weiss, Sarah Yerian, Yujing Zhao, Sarah G.H. Sapp, and Vitaliano A. Cama. Progress toward global dracunculiasis (guinea worm disease) eradication, january 2023–june 2024. Morbidity and Mortality Weekly Report, 73:991-998, Nov 2024. URL: https://doi.org/10.15585/mmwr.mm7344a1, doi:10.15585/mmwr.mm7344a1. This article has 14 citations.

  6. (delea2024slayingtheserpent pages 1-2): Maryann G. Delea, Alexandra Sack, Obiora A. Eneanya, Elizabeth Thiele, Sharon L. Roy, Dieudonne Sankara, Kashef Ijaz, Donald R. Hopkins, and Adam J. Weiss. Slaying the serpent: a research agenda to expand intervention development and accelerate guinea worm eradication efforts. The American Journal of Tropical Medicine and Hygiene, 111:12-25, Sep 2024. URL: https://doi.org/10.4269/ajtmh.23-0889, doi:10.4269/ajtmh.23-0889. This article has 5 citations.

  7. (hopkins2024progresstowardglobal pages 6-7): Donald R. Hopkins, Adam J. Weiss, Sarah Yerian, Yujing Zhao, Sarah G.H. Sapp, and Vitaliano A. Cama. Progress toward global dracunculiasis (guinea worm disease) eradication, january 2023–june 2024. Morbidity and Mortality Weekly Report, 73:991-998, Nov 2024. URL: https://doi.org/10.15585/mmwr.mm7344a1, doi:10.15585/mmwr.mm7344a1. This article has 14 citations.

  8. (eneanya2024predictingtheenvironmental pages 1-1): Obiora A. Eneanya, Maryann G. Delea, Jorge Cano, Philip Ouakou Tchindebet, Robert L. Richards, Yujing Zhao, Abdalla Meftuh, Karmen Unterwegner, Sarah Anne J. Guagliardo, Donald R. Hopkins, and Adam Weiss. Predicting the environmental suitability and identifying climate and sociodemographic correlates of guinea worm (dracunculus medinensis) in chad. The American Journal of Tropical Medicine and Hygiene, 111:26-35, Sep 2024. URL: https://doi.org/10.4269/ajtmh.23-0681, doi:10.4269/ajtmh.23-0681. This article has 4 citations.

  9. (eneanya2024predictingtheenvironmental pages 4-6): Obiora A. Eneanya, Maryann G. Delea, Jorge Cano, Philip Ouakou Tchindebet, Robert L. Richards, Yujing Zhao, Abdalla Meftuh, Karmen Unterwegner, Sarah Anne J. Guagliardo, Donald R. Hopkins, and Adam Weiss. Predicting the environmental suitability and identifying climate and sociodemographic correlates of guinea worm (dracunculus medinensis) in chad. The American Journal of Tropical Medicine and Hygiene, 111:26-35, Sep 2024. URL: https://doi.org/10.4269/ajtmh.23-0681, doi:10.4269/ajtmh.23-0681. This article has 4 citations.

  10. (eneanya2024predictingtheenvironmental pages 1-3): Obiora A. Eneanya, Maryann G. Delea, Jorge Cano, Philip Ouakou Tchindebet, Robert L. Richards, Yujing Zhao, Abdalla Meftuh, Karmen Unterwegner, Sarah Anne J. Guagliardo, Donald R. Hopkins, and Adam Weiss. Predicting the environmental suitability and identifying climate and sociodemographic correlates of guinea worm (dracunculus medinensis) in chad. The American Journal of Tropical Medicine and Hygiene, 111:26-35, Sep 2024. URL: https://doi.org/10.4269/ajtmh.23-0681, doi:10.4269/ajtmh.23-0681. This article has 4 citations.

  11. (simonetti2023thecurrentstate pages 2-4): Omar Simonetti, V. Zerbato, C. Maurel, Lavinia Cosimi, Stella Babich, Fabio Cavalli, Stefano Di Bella, D. Pavia, C. Pesaresi, and Roberto Luzzati. The current state of knowledge on dracunculiasis: a narrative review of a rare neglected disease. Le infezioni in medicina, 31 4:500-508, Dec 2023. URL: https://doi.org/10.53854/liim-3104-9, doi:10.53854/liim-3104-9. This article has 6 citations.

  12. (hopkins2023progresstowarderadication pages 1-2): DR Hopkins. Progress toward eradication of dracunculiasis—worldwide, january 2022–june 2023. Unknown journal, 2023.

  13. (hopkins2023progresstowarderadication pages 2-3): DR Hopkins. Progress toward eradication of dracunculiasis—worldwide, january 2022–june 2023. Unknown journal, 2023.

  14. (hopkins2024progresstowardglobal pages 5-6): Donald R. Hopkins, Adam J. Weiss, Sarah Yerian, Yujing Zhao, Sarah G.H. Sapp, and Vitaliano A. Cama. Progress toward global dracunculiasis (guinea worm disease) eradication, january 2023–june 2024. Morbidity and Mortality Weekly Report, 73:991-998, Nov 2024. URL: https://doi.org/10.15585/mmwr.mm7344a1, doi:10.15585/mmwr.mm7344a1. This article has 14 citations.

  15. (hopkins2023progresstowarderadication pages 6-7): DR Hopkins. Progress toward eradication of dracunculiasis—worldwide, january 2022–june 2023. Unknown journal, 2023.

  16. (agua2025comparativeanalysisof pages 67-71): J Agua. Comparative analysis of risk factors associated with guinea worm disease in five endemic countries. Unknown journal, 2025.

  17. (tutu2023stoppingandtracing pages 1-3): D Tutu. Stopping and tracing guinea worm transmission in 2023. Unknown journal, 2023.

  18. (cairncross2002dracunculiasis(guineaworm pages 1-1): Sandy Cairncross, Ralph Muller, and Nevio Zagaria. Dracunculiasis (guinea worm disease) and the eradication initiative. Clinical Microbiology Reviews, 15:223-246, Apr 2002. URL: https://doi.org/10.1128/cmr.15.2.223-246.2002, doi:10.1128/cmr.15.2.223-246.2002. This article has 237 citations and is from a highest quality peer-reviewed journal.

  19. (eneanya2024predictingtheenvironmental pages 8-9): Obiora A. Eneanya, Maryann G. Delea, Jorge Cano, Philip Ouakou Tchindebet, Robert L. Richards, Yujing Zhao, Abdalla Meftuh, Karmen Unterwegner, Sarah Anne J. Guagliardo, Donald R. Hopkins, and Adam Weiss. Predicting the environmental suitability and identifying climate and sociodemographic correlates of guinea worm (dracunculus medinensis) in chad. The American Journal of Tropical Medicine and Hygiene, 111:26-35, Sep 2024. URL: https://doi.org/10.4269/ajtmh.23-0681, doi:10.4269/ajtmh.23-0681. This article has 4 citations.

  20. (sudan2024datefebruary26 pages 3-5): S Sudan. Date: february 26, 2024 from: who collaborating center for dracunculiasis eradication, cdc subject: guinea worm wrap-up# 306 to: addressees. Unknown journal, 2024.

  21. (eneanya2024predictingtheenvironmental pages 9-10): Obiora A. Eneanya, Maryann G. Delea, Jorge Cano, Philip Ouakou Tchindebet, Robert L. Richards, Yujing Zhao, Abdalla Meftuh, Karmen Unterwegner, Sarah Anne J. Guagliardo, Donald R. Hopkins, and Adam Weiss. Predicting the environmental suitability and identifying climate and sociodemographic correlates of guinea worm (dracunculus medinensis) in chad. The American Journal of Tropical Medicine and Hygiene, 111:26-35, Sep 2024. URL: https://doi.org/10.4269/ajtmh.23-0681, doi:10.4269/ajtmh.23-0681. This article has 4 citations.